GB0312844D0 - Use of compounds in medicine - Google Patents
Use of compounds in medicineInfo
- Publication number
- GB0312844D0 GB0312844D0 GBGB0312844.4A GB0312844A GB0312844D0 GB 0312844 D0 GB0312844 D0 GB 0312844D0 GB 0312844 A GB0312844 A GB 0312844A GB 0312844 D0 GB0312844 D0 GB 0312844D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- medicine
- compounds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Neurosurgery (AREA)
- Organic Chemistry (AREA)
- Pain & Pain Management (AREA)
- Psychology (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Rheumatology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0312844.4A GB0312844D0 (en) | 2003-06-04 | 2003-06-04 | Use of compounds in medicine |
PCT/GB2004/002301 WO2004108141A2 (en) | 2003-06-04 | 2004-06-01 | Bach-o-protein coupled receptor releated methods |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0312844.4A GB0312844D0 (en) | 2003-06-04 | 2003-06-04 | Use of compounds in medicine |
Publications (1)
Publication Number | Publication Date |
---|---|
GB0312844D0 true GB0312844D0 (en) | 2003-07-09 |
Family
ID=9959315
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB0312844.4A Ceased GB0312844D0 (en) | 2003-06-04 | 2003-06-04 | Use of compounds in medicine |
Country Status (2)
Country | Link |
---|---|
GB (1) | GB0312844D0 (en) |
WO (1) | WO2004108141A2 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20100284984A1 (en) * | 2007-07-30 | 2010-11-11 | University Of Rochester | Adenosine and its mimetics. modulators, transport inhibitors, and receptor agonists as a therapeutic tool to replace or improve the efficacy of deep brain stimulation |
ITTO20110576A1 (en) * | 2011-06-30 | 2012-12-31 | Medicam Health Science S R L | COMPOSITION INCLUDING THE ASSOCIATION OF MELISSA PHYTO-EXTRACT, METHYLAMIDE AND A SOURCE OF NUCLEOTIDES AND / OR NUCLEOSIDES AND ITS USE IN THE TREATMENT OF HEADACHE AND HEMICRYANES |
WO2019204392A1 (en) * | 2018-04-17 | 2019-10-24 | Purdue Research Foundation | Modifying surface of a live cell and the uses thereof |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5547942A (en) * | 1994-01-04 | 1996-08-20 | Rapaport; Eliezer | Method of treatment of diabetes mellitus by administration of adenosine 5'-t |
US6440455B1 (en) * | 1997-09-02 | 2002-08-27 | Children's Medical Center Corporation | Methods for modulating the axonal outgrowth of central nervous system neurons |
AU2100901A (en) * | 1999-12-15 | 2001-06-25 | Bruce H. Levin | Compositions, kits, apparatus, and methods for inhibiting cephalic inflammation |
AU2603101A (en) * | 1999-12-22 | 2001-07-03 | Inspire Pharmaceuticals, Inc. | Method of treating gastrointestinal tract disease with purinergic receptor agonists |
AU1252102A (en) * | 2000-11-07 | 2002-05-21 | Paradigm Therapeutics Ltd | Receptor |
US6946244B2 (en) * | 2001-08-07 | 2005-09-20 | Euroscreen, S.A. | Methods of identifying a ligand, an agonist, and an antagonist of G protein coupled receptor GPR86 (P2Y13) |
US20030059857A1 (en) * | 2001-09-17 | 2003-03-27 | Schering Corporation | G-protein coupled receptor and methods |
-
2003
- 2003-06-04 GB GBGB0312844.4A patent/GB0312844D0/en not_active Ceased
-
2004
- 2004-06-01 WO PCT/GB2004/002301 patent/WO2004108141A2/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2004108141A2 (en) | 2004-12-16 |
WO2004108141A3 (en) | 2005-03-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB0324761D0 (en) | Use of compounds in therapy | |
IL176248A0 (en) | N-substituted-n-sulfonylaminocyclopropane compounds and pharmaceutical use thereof | |
GB0307918D0 (en) | Therapeutic use | |
IL172316A0 (en) | Novel compounds and their use in therapy | |
EP1682136A4 (en) | Therapeutic compounds and uses thereof | |
GB0305150D0 (en) | Use of therapeutic compounds | |
GB0306604D0 (en) | Second medical use | |
GB0300804D0 (en) | Compounds and their use | |
GB0300805D0 (en) | Compounds and their use | |
GB0312844D0 (en) | Use of compounds in medicine | |
GB0301143D0 (en) | Compounds and their use | |
GB0312845D0 (en) | Use of componds in medicine | |
GB0317133D0 (en) | Compounds and their use | |
GB0322195D0 (en) | Compounds and their medical uses | |
GB0322194D0 (en) | Compounds and their medical uses | |
GB0322990D0 (en) | Therapeutic use | |
GB0304820D0 (en) | Compounds and their use | |
GB0314293D0 (en) | Compounds and their use | |
GB0311820D0 (en) | Compounds and their use | |
GB0301146D0 (en) | Compounds and their use | |
GB0314295D0 (en) | Compounds and their use | |
GB0321442D0 (en) | Compounds and their use | |
GB0321301D0 (en) | Compounds and their use | |
GB0320064D0 (en) | Compounds and their use | |
GB0301147D0 (en) | Compounds and their use |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |